Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms

Eur J Vasc Endovasc Surg. 2000 Jun;19(6):630-5. doi: 10.1053/ejvs.1999.1057.

Abstract

Objectives: to investigate the presence of Chlamydia pneumoniae in the wall of abdominal aortic aneurysms (AAAs) and in the aortas of patients without a history of cardiovascular disease.

Design: case-control study.

Materials: twenty-six consecutive patients operated for AAA were compared to 17 controls.

Methods: aorta was obtained at surgery or autopsy (controls) and prepared for immunohistochemical (IHC) analysis and culture for C. pneumoniae. Throat swabs from 14/26 patients were analysed by PCR for C. pneumoniae. Blood was obtained from 24/26 patients and from 178 70-year-old males.

Results: C. pneumoniae was detected in the aortic aneurysms of 20/26 patients by IHC. C. pneumoniae was cultured from 10 of the 20 IHC-positive patients. Only 1/17 controls was positive for C. pneumoniae by IHC (p=0.0001). PCR was positive for C. pneumoniae in 5/14 patients. Serological analysis by microimmunofluoresence (MIF) showed significantly more high titres of the specific antibodies to C. pneumoniae in patients than in age-matched male controls.

Conclusions: we conclude that C. pneumoniae is often present in AAAs in a viable form and that C. pneumoniae is linked to the pathogenesis of AAA.

Publication types

  • Comparative Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Bacterial / analysis
  • Aorta, Abdominal / microbiology*
  • Aorta, Abdominal / pathology
  • Aortic Aneurysm, Abdominal / microbiology*
  • Aortic Aneurysm, Abdominal / pathology
  • Biomarkers / analysis
  • Chlamydia Infections / microbiology*
  • Chlamydia Infections / pathology
  • Chlamydophila pneumoniae / genetics
  • Chlamydophila pneumoniae / immunology
  • Chlamydophila pneumoniae / isolation & purification*
  • DNA, Bacterial / analysis
  • Humans
  • Immunoglobulin A / immunology
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Retrospective Studies
  • Risk Factors

Substances

  • Antibodies, Bacterial
  • Biomarkers
  • DNA, Bacterial
  • Immunoglobulin A
  • Immunoglobulin G